NM_020686.6:c.749G>A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_020686.6(ABAT):c.749G>A(p.Arg250Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000421 in 1,613,996 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R250G) has been classified as Uncertain significance.
Frequency
Consequence
NM_020686.6 missense
Scores
Clinical Significance
Conservation
Publications
- GABA aminotransaminase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Orphanet, G2P
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000263  AC: 4AN: 152110Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.0000795  AC: 20AN: 251484 AF XY:  0.0000956   show subpopulations 
GnomAD4 exome  AF:  0.0000438  AC: 64AN: 1461886Hom.:  2  Cov.: 32 AF XY:  0.0000550  AC XY: 40AN XY: 727244 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000263  AC: 4AN: 152110Hom.:  0  Cov.: 33 AF XY:  0.0000538  AC XY: 4AN XY: 74288 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Gamma-aminobutyric acid transaminase deficiency    Uncertain:1 
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ABAT protein function. ClinVar contains an entry for this variant (Variation ID: 460330). This variant has not been reported in the literature in individuals affected with ABAT-related conditions. This variant is present in population databases (rs375002262, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 250 of the ABAT protein (p.Arg250Gln). -
not provided    Uncertain:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at